featured
Venetoclax Plus Decitabine as a Bridge to Allogeneic HSCT in Older Patients With AML
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet Haematology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Venetoclax plus decitabine as a bridge to allogeneic haematopoietic stem-cell transplantation in older patients with acute myeloid leukaemia (VEN-DEC GITMO): final report of a multicentre, single-arm, phase 2 trial
Lancet Haematol 2024 Sep 20;[EPub Ahead of Print], D Russo, N Polverelli, S Bernardi, S Santarone, M Farina, E Borlenghi, F Onida, L Castagna, S Bramanti, AM Carella, R Sorasio, M Martino, C Alati, A Olivieri, G Beltrami, A Curti, C Vetro, S Leotta, V Mancini, E Terruzzi, M Bernardi, P Galieni, P Musto, R Cerretti, L Giaccone, C Skert, V Radici, M Vezzoli, S Calza, A Leoni, L Garuffo, C Bonvicini, S Pellizzeri, M Malagola, F CiceriFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.